1. Factors Correlated with Smoking Cessation Success in Older Adults: A Retrospective Cohort Study in Taiwan
- Author
-
Wei-Hsin Huang, Ching-Hui You, Hsin-Lung Chan, I-Jung Lu, Chih-Po Chang, and Lee-Ching Hwang
- Subjects
Fagerstrom Test for Nicotine Dependence ,Male ,health care facilities, manpower, and services ,Health, Toxicology and Mutagenesis ,media_common.quotation_subject ,medicine.medical_treatment ,Population ,Taiwan ,lcsh:Medicine ,predictor ,030204 cardiovascular system & hematology ,Affect (psychology) ,Article ,nicotine replacement therapy ,Cohort Studies ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Medicine ,Humans ,030212 general & internal medicine ,Varenicline ,education ,media_common ,Aged ,Retrospective Studies ,Aged, 80 and over ,education.field_of_study ,Smoking Cessation Agents ,business.industry ,lcsh:R ,Public Health, Environmental and Occupational Health ,Retrospective cohort study ,social sciences ,Abstinence ,Middle Aged ,Nicotine replacement therapy ,humanities ,Tobacco Use Cessation Devices ,varenicline ,chemistry ,smoke cessation ,Smoking cessation ,Female ,Smoking Cessation ,older smoker ,business ,Demography - Abstract
Smoking cessation in the elderly is very important. This study aims to explore the success rate of smoking cessation in the elderly and the factors that predict the success of smoking cessation. We collected data from smokers &ge, 60 years who visited a medical center in Taiwan during 2017. All patients were prescribed either varenicline or nicotine replacement therapy (NRT) for smoking cessation. The participants were asked about their smoking status after treatment. In total, 129 participants were enrolled. The three- or six-month point abstinence rate was 48.1%. No significant difference was found among baseline characteristics (including age, gender, underlying diseases, smoking duration, daily consumption amount of cigarette, carbon monoxide concentration, Fagerströ, m test for nicotine dependence scores, and treatment method) between quitters and non-quitters, except for the type of medication used. The proportion of quitters using varenicline was significantly higher than that of non-quitters. Multivariate regression analyses showed that the patients who received varenicline were 3.22 times more likely to quit smoking than those who received NRT. Therefore, we suggest that varenicline use may help in smoking cessation in older adults, compared to NRT. Other baseline characteristics may not affect the success rate of smoking cessation in this population.
- Published
- 2019